Amount Raised
$11.3 Million
Round Type
Series A
LondonBiotechnology ResearchInvestors
Description
Baseimmune, a biotech company that uses proprietary, deep learning AI to predict future pathogen mutations to generate novel vaccines, announced the close of $11.3 million [£9 million] in Series A funding led by new investors MSD Global Health Innovation Fund and IQ Capital, with participation from existing investors including Hoxton Ventures, Creator Fund, Beast Ventures and Maki.vc. The funding will enable Baseimmune to accelerate development of its three vaccine candidates currently in preclinical development for African swine fever, coronavirus, and malaria.
Quick answer
Baseimmune raised $11.3 Million in a Series A round, dated February 26, 2024. Investors: MSD Global Health Innovation Fund, Maki.Vc, Beast Ventures, Creator Fund, Hoxton Ventures and IQ Capital. Baseimmune is based in London, England, United Kingdom.
- How much did Baseimmune raise?
- Baseimmune raised $11.3 Million in a Series A round on February 26, 2024.
- Who invested in Baseimmune?
- MSD Global Health Innovation Fund, Maki.Vc, Beast Ventures, Creator Fund, Hoxton Ventures and IQ Capital are named as investors in this round.
- What does Baseimmune do?
- Baseimmune was founded in 2019 as a discovery phase start-up in the antigen discovery and vaccine development field.
- Where is Baseimmune based and how big is it?
- Baseimmune is based in London, England, United Kingdom.
- Who are the decision-makers at Baseimmune?
- Fundz holds 1 contact at Baseimmune. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology Research around the same time
Companies in the same sectors as Baseimmune that raised within 45 days of this round, from Fundz verified event records.
- Bio-AI Health Inc. raised $500K (Seed) on April 5, 2024.
- eFeed raised $10M (Seed) on February 21, 2024.
- VRG Therapeutics raised $15M (Series B) on February 20, 2024.
- Colipi raised $1.9M (Seed) on February 19, 2024.
- FreezeM raised $14M (Series A) on February 15, 2024.
- SingleTimeMicroneedles raised an undisclosed amount (Pre-Seed) on February 14, 2024.
Who to call at Baseimmune, and when
A new round usually means Baseimmune is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Baseimmune raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Baseimmune, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Baseimmune. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Baseimmune raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBaseimmune raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.